An increase in inflammatory molecules, like CD40L and MCP‐1, is linked to the later stages of atherosclerotic cerebrovascular disease and raises the likelihood of recurrent cardiovascular events in diabetic patients with stroke (Davì et al., 2009). Here, CCL2 is linked to stroke disorder.